TGF-β is a critical mediator of acute lung injury

被引:388
作者
Pittet, JF
Griffiths, MJD
Geiser, T
Kaminski, N
Dalton, SL
Huang, XZ
Brown, LAS
Gotwals, PJ
Koteliansky, VE
Matthay, MA
Sheppard, D
机构
[1] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94110 USA
[4] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94110 USA
[5] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA
[6] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[7] USA Biogen Inc, Cambridge, MA USA
[8] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[9] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
关键词
D O I
10.1172/JCI11963
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have shown that the integrin alphav betaG activates latent TGF-beta in the lungs and skin. We show here that mice lacking this integrin are completely protected from pulmonary edema in a model of bleomycin-induced acute lung injury (ALI). Pharmacologic inhibition of TGF-beta also protected wild-type mice from pulmonary edema induced by bleomycin or Escherichia coli endotoxin. TGF-beta directly increased alveolar epithelial permeability in vitro by a mechanism that involved depletion of intracellular glutathione. These data suggest that integrin-mediated local activation of TGF-beta is critical to the development of pulmonary edema in ALI and that blocking TGF-beta or its activation could be effective treatments for this currently untreatable disorder.
引用
收藏
页码:1537 / 1544
页数:8
相关论文
共 29 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   Transforming growth factor-beta(1) is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: Transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase [J].
Arsalane, K ;
Dubois, CM ;
Muanza, T ;
Begin, R ;
Boudreau, F ;
Asselin, C ;
Cantin, AM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (05) :599-607
[3]   TRANSFORMING GROWTH FACTOR-BETA-1 IS PRESENT AT SITES OF EXTRACELLULAR-MATRIX GENE-EXPRESSION IN HUMAN PULMONARY FIBROSIS [J].
BROEKELMANN, TJ ;
LIMPER, AH ;
COLBY, TV ;
MCDONALD, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6642-6646
[4]   OXIDIZED GLUTATHIONE IS INCREASED IN THE ALVEOLAR FLUID OF PATIENTS WITH THE ADULT-RESPIRATORY-DISTRESS-SYNDROME [J].
BUNNELL, E ;
PACHT, ER .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (05) :1174-1178
[5]   Early detection of type III procollagen peptide in acute lung injury - Pathogenetic and prognostic significance [J].
Chesnutt, AN ;
Matthay, MA ;
Tibayan, FA ;
Clark, JG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) :840-845
[6]   TGF-BETA-1 PRODUCES A PROOXIDANT EFFECT ON BOVINE PULMONARY-ARTERY ENDOTHELIAL-CELLS IN CULTURE [J].
DAS, SK ;
FANBURG, BL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04) :L249-L254
[7]  
DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141
[8]   EFFECT OF ANTIBODY TO TRANSFORMING GROWTH-FACTOR-BETA ON BLEOMYCIN-INDUCED ACCUMULATION OF LUNG COLLAGEN IN MICE [J].
GIRI, SN ;
HYDE, DM ;
HOLLINGER, MA .
THORAX, 1993, 48 (10) :959-966
[9]   Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats [J].
Guidot, DM ;
Modelska, K ;
Lois, M ;
Jain, L ;
Moss, IM ;
Pittet, JF ;
Brown, LAS .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 279 (01) :L127-L135
[10]   POTENTIATING EFFECTS OF OXYGEN IN LUNGS DAMAGED BY METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL, CADMIUM CHLORIDE, OLEIC-ACID, AND ANTI-TUMOR DRUGS [J].
HAKKINEN, PJ ;
MORSE, CC ;
MARTIN, FM ;
DALBEY, WE ;
HASCHEK, WM ;
WITSCHI, HR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1983, 67 (01) :55-69